Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?

Kathleen E. Corey, Naga Chalasani

Research output: Contribution to journalArticle

3 Citations (Scopus)
Original languageEnglish
Pages (from-to)1503-1505
Number of pages3
JournalHepatology
Volume54
Issue number5
DOIs
StatePublished - Nov 2011

Fingerprint

Thiazolidinediones
Losartan
Metformin
Fatty Liver
Clinical Trials
Therapeutics
Non-alcoholic Fatty Liver Disease

ASJC Scopus subject areas

  • Hepatology

Cite this

Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials? / Corey, Kathleen E.; Chalasani, Naga.

In: Hepatology, Vol. 54, No. 5, 11.2011, p. 1503-1505.

Research output: Contribution to journalArticle

@article{7fb498a65da748e6a7a156d99148d777,
title = "Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?",
author = "Corey, {Kathleen E.} and Naga Chalasani",
year = "2011",
month = "11",
doi = "10.1002/hep.24696",
language = "English",
volume = "54",
pages = "1503--1505",
journal = "Hepatology",
issn = "0270-9139",
publisher = "John Wiley and Sons Ltd",
number = "5",

}

TY - JOUR

T1 - Should combination therapy be the paradigm for future nonalcoholic steatohepatitis clinical trials?

AU - Corey, Kathleen E.

AU - Chalasani, Naga

PY - 2011/11

Y1 - 2011/11

UR - http://www.scopus.com/inward/record.url?scp=80055047289&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80055047289&partnerID=8YFLogxK

U2 - 10.1002/hep.24696

DO - 10.1002/hep.24696

M3 - Article

C2 - 21953015

AN - SCOPUS:80055047289

VL - 54

SP - 1503

EP - 1505

JO - Hepatology

JF - Hepatology

SN - 0270-9139

IS - 5

ER -